PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2008
CASE
AUTH/2426 AstraZeneca

AUTH/2426-2429/8/11: Onglyza advert in Health Service Journal (AstraZeneca/Bristol-Myers Squibb) – no breach on appeal

Public complaints said an Onglyza advertorial in Health Service Journal was inappropriate and too technical. Panel found no public advertising breach but…

2018
CASE
AUTH/3089/9/18 Merck Serono ⭐ Case of the Week

PMCPA AUTH/3089/9/18: Director v Merck Serono (Clinical trial disclosure) – Outwith scope / No breach

PMCPA case AUTH/3089/9/18 (Director v Merck Serono) concerned clinical trial disclosure. Under the 2016 ABPI Code it was ruled outwith the scope…

2018
CASE
AUTH/3079/9/18 Pfizer

AUTH/3079/9/18: Director v Pfizer β€” Clinical trial disclosure on EUCTR (No breach after appeal)

BMJ EU Trials Tracker data suggested 7 Pfizer trials lacked EUCTR results. Panel initially found Clause 9.1 breaches for 3 trials, but…

2012
CASE
AUTH/2501/4/12 Meda

AUTH/2501/4/12: ALK-AbellΓ³ v Meda β€” β€˜Risks of changing from EpiPen’ booklet (No breach)

ALK-AbellΓ³ challenged Meda’s booklet heading β€˜The risks of changing from EpiPen Auto-Injector’, alleging it implied switching to Jext was life-threatening and disparaging.…

2012
CASE
AUTH/2490/3/12 Bayer

Bayer Healthcare voluntary admission: uncertified Xarelto joint-working/formulary documents used by contractor (AUTH/2490/3/12)

A contractor created and circulated three uncertified Xarelto documents (business case, project initiation, patient pathway). Panel found disguised promotion, misleading/unbalanced claims incl…

2011
CASE
AUTH/2467/12/11 Boehringer Ingelheim

Boehringer Ingelheim & Pfizer: BTS exhibitor listing called Spiriva/Respimat β€˜new’ and placebo inhaler devices were handed out from the stand (AUTH/2467/12/11, AUTH/2468/12/11)

At BTS Winter 2011, exhibitor text described Spiriva and Respimat as β€˜new’ despite long UK availability, and placebo HandiHaler/Respimat devices were provided…

2012
CASE
AUTH/2534/10/12 Roche Products ⭐ Case of the Week

AUTH/2534/10/12: Anonymous v Roche – Alleged pressure and inducements linked to rheumatoid arthritis project (No breach)

Anonymous complaint alleged Roche pressured a hospital pharmacist to continue an RA project and provided drinks/money. Panel found no supporting evidence and…

2013
CASE
AUTH/2579/2/13 Bayer

Bayer: β€˜Mirena training workshop’ weblink found misleading (EvoInserter training expectation) β€” AUTH/2579/2/13

A GP said he was misled into attending what he thought was EvoInserter hands-on training. PMCPA found the Mirena website β€˜training workshop’…

2012
CASE
AUTH/2546/11/12 Astellas

Astellas (and others) criticised for supporting urology meeting at 5-star venue with golf and gala dinner (AUTH/2546/11/12 and related cases)

Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast. Panel said the programme created an unacceptable impression (5-star…

2013
CASE
AUTH/2596/4/13 Leo

AUTH/2596/4/13: Almirall/Director v Leo Pharma – Picato ads and alleged breach of undertaking (No breach)

Almirall alleged Leo’s Picato ads breached a prior PMCPA undertaking and brought discredit (Clauses 25, 2). Panel found the ads predated the…

2013
CASE
AUTH/2573/1/13 Gedeon Richter

AUTH/2573/1/13: Ex-employee v Gedeon Richter (FIGO Rome sponsorship) – No breach

Ex-employee alleged excessive sponsorship of 33 UK HCPs to FIGO Rome 2012. Panel reviewed costs (travel, hotel, dinners) under Clause 19.1 and…

2012
CASE
Bayer ⭐ Case of the Week

Bayer: late-night hotel bar drinks at ISTH congress ruled not β€œsubsistence” (breach Clause 19.1)

Anonymous HCP alleged late-night hotel bar entertaining at ISTH Amsterdam. Panel accepted Bayer account of 4 drinks bought near midnight while waiting…

2012
CASE
GrΓΌnenthal

GrΓΌnenthal breached Clause 15.4 after sales email blurred β€œinteractions” with call vs contact rates

A senior sales email about CRM data entry also set β€œ2+ target interactions/day” and β€œ5–7 total/day” without clearly distinguishing call rates from…

2013
CASE
AUTH/2679/11/13 Bayer

AUTH/2679/11/13: Advertising agency employee v Bayer β€” Sativex ads on a creative media website (No breach)

Sativex POM ads appeared on a US creative media site after an awards submission. PMCPA said the Code applied (UK cost referenced)…

2015
CASE
AUTH/2801/11/15 Janssen

Janssen voluntary admission: Stelara journal insert ran with outdated prescribing information (AUTH/2801/11/15)

A Stelara bound-in journal advert ran with November 2014 prescribing information after the PI was updated in June 2015. Despite publisher error,…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training